Advanced Solid Tumor Clinical Trials Database - Free Access to 382 Studies
Access comprehensive clinical trial information for Advanced Solid Tumor through Pure Global AI's free database. This collection includes 382 clinical trials across multiple phases including Phase 1, Phase 1/2, Early Phase 1. Currently, 198 trials are actively recruiting participants.
Research for Advanced Solid Tumor is being conducted in China, United States of America, Australia and 7+ other countries. Leading sponsors include Jiangsu HengRui Medicine Co., Ltd. and Novartis Pharmaceuticals. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
M9466 as Single Agent or in Combination With Tuvusertib in Advanced Solid Tumors (DDRiver 501)
A Study of FDA022-BB05 in Advanced/Metastatic Solid Tumors
Safety and Modulation of Adaptive Immunity by Iscador® Qu Viscum Album Extract in Patients With Advanced, Recurrent or Metastatic Cancers Treated With Immune Checkpoint Inhibitors
CAN1012 Combined With PD-1 in Patients With Solid Tumors
γδ T-PD-1 Ab Cells in the Treatment of Advanced Solid Tumors
A Study of MHB036C for Advanced Solid Tumor
A Food Effect Study of SPH5030 Tablets.
Implementation of Liquid Biopsies During Routine Clinical Care in Patients With Advanced Malignancies (LIQPLAT)
Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors
TIL for Patients With Advanced Solid Tumor
Clinical Trial of BT02 in Patients With Advanced Solid Tumors
A Study of MHB039A for Advanced Solid Tumor
ARTEMIS-101: A Study of HS-20093 Combinations in Patients With Advanced Solid Tumors
A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors
A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors
A Study of HC006 in Subjects With Advanced Solid Tumors
A Clinical Trial of SIBP-A13 Injection in the Treatment of Advanced Malignant Solid Tumor Patients.
A Study of BRY805 in Participants With Advanced Solid Tumors
A Phase 1 Study of BB102 in Participants With Advanced Solid Tumors
A First-in-Human, Phase 1/2 Study of LAT010 in Patients With Advanced Solid Tumors (LIGHTSPEED-1)
Pure Global AI provides free access to 382 clinical trials studying Advanced Solid Tumor, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Jiangsu HengRui Medicine Co., Ltd., Novartis Pharmaceuticals, Shanghai YingLi Pharmaceutical Co. Ltd., among others.